Antimicrobial susceptibility profiles of Staphylococcus aureus isolated in 2007 from French patients with bloodstream infections: Goodbye hVISA, welcome Geraldine?

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1297-1299

  Gallon, Olivier ^a   Lamy, Brigitte ^b   Laurent, Frédéric ^b   Reverdy, Marie Elisabeth ^c,d   Doucet Populaire, Florence ^e,f   Decousser, Jean Winoc ^e  

^a Centre Hospitalier de Dourdan   (France)

^b Centre Hospitalier du Bassin de Thau   (France)

^c INSERM   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Antibiotic resistance; Bacteraemia; Heteroresistance; Vancomycin

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; MACROLIDE; OXACILLIN; PRISTINAMYCIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENETICS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; FRANCE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FRANCE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 77953488390     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq128     Document Type: Letter

References (6)

1. Decousser JW, Pina P, Picot F et al. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: A French prospective national survey. J Antimicrob Chemother 2003; 51: 1213-22. doi:10.1093/jac/dkg201
2. Gallon O, Guillet-Caruba C, Lamy B et al. In vitro activity of daptomycin against staphylococci isolated from bacteraemia and community-onset skin and soft tissues infections in France: Data from two nationwide studies. Eur J Clin Microbiol Infect Dis 2009; 28: 1209-15. doi:10.1007/s10096-009-0764-y
3. Maor Y, Hagin M, Belausov N et al. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 2009; 199: 619-24. doi:10.1086/596629
4. El Solh N, Davi M, Morvan A et al. Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides. J Antimicrob Chemother 2003; 52: 691-4. doi:10.1093/jac/dkg400
5. Durand G, Bes M, Meunier H et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 2006; 44: 847-53. doi:10.1128/JCM.44.3.847-853.2006
6. Laurent F, Lelièvre H, Cornu M et al. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001; 47: 277-83. doi:10.1093/jac/47.3.277